Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAFASITAMAB-CXIX vs TALC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAFASITAMAB-CXIX vs TALC: Safety Overview

Metric TAFASITAMAB-CXIX TALC
Total FAERS Reports 736 933
Deaths Reported 108 222
Death Rate 14.7% 23.8%
Hospitalizations 117 69
Average Patient Age 68.1 yrs 56.6 yrs
% Female Patients 47.5% 79.6%
FDA Approval Date N/A Dec 15, 2003
Manufacturer N/A Novatech SA
Route N/A INTRAPLEURAL
Marketing Status Prescription Prescription